[Lethal midline granuloma (LMG)]. 1990

J Rolski, and K Smolak, and A Gruchała, and R Drazek
Kliniki Chemioterapii Oddziału Krakowskiego Centrum Onkologii Instytutu im M. Skłodowskiej-Curie.

UI MeSH Term Description Entries
D009302 Nasopharyngeal Diseases Pathological processes involving the NASOPHARYNX. Diseases of Nasopharynx,Disease, Nasopharyngeal,Diseases, Nasopharyngeal,Nasopharyngeal Disease,Nasopharynx Disease,Nasopharynx Diseases
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005260 Female Females
D006103 Granuloma, Lethal Midline A condition that is characterized by inflammation, ulceration, and perforation of the nose and the PALATE with progressive destruction of midline facial structures. This syndrome can be manifested in several diseases including the nasal type of EXTRANODAL NK-T-CELL LYMPHOMA and GRANULOMATOSIS WITH POLYANGIITIS. Granuloma Gangraenescens,Lethal Midline Granuloma,Polymorphic Reticulosis,Granulomas, Lethal Midline,Lethal Midline Granulomas,Midline Granuloma, Lethal,Midline Granulomas, Lethal,Polymorphic Reticuloses,Reticuloses, Polymorphic,Reticulosis, Polymorphic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Rolski, and K Smolak, and A Gruchała, and R Drazek
January 1990, Minerva ortognatodontica,
J Rolski, and K Smolak, and A Gruchała, and R Drazek
October 1976, Plastic and reconstructive surgery,
J Rolski, and K Smolak, and A Gruchała, and R Drazek
December 1985, Orvosi hetilap,
J Rolski, and K Smolak, and A Gruchała, and R Drazek
January 1985, Annales de dermatologie et de venereologie,
J Rolski, and K Smolak, and A Gruchała, and R Drazek
January 1964, Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology,
J Rolski, and K Smolak, and A Gruchała, and R Drazek
January 2004, Lijecnicki vjesnik,
J Rolski, and K Smolak, and A Gruchała, and R Drazek
January 1970, Harefuah,
J Rolski, and K Smolak, and A Gruchała, and R Drazek
January 2013, Indian dermatology online journal,
J Rolski, and K Smolak, and A Gruchała, and R Drazek
February 1962, Radiology,
J Rolski, and K Smolak, and A Gruchała, and R Drazek
January 1992, Vestnik otorinolaringologii,
Copied contents to your clipboard!